Boston Scientific Corporation
(NYSE : BSX)

( )
BSX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ABMDABIOMED, Inc.
-2.51%427.293.3%$598.54m
ISRGIntuitive Surgical, Inc.
-0.80%483.212.4%$420.67m
MDTMedtronic PLC
0.58%86.800.6%$414.41m
ALGNAlign Technology, Inc.
-1.76%353.276.3%$350.51m
SYKStryker Corporation
1.28%171.991.3%$342.59m
BSXBoston Scientific Corporation
1.49%32.631.1%$323.32m
ABTAbbott Laboratories
0.28%61.920.8%$312.94m
BDXBecton, Dickinson and Company
1.85%237.561.1%$282.08m
TMOThermo Fisher Scientific Inc.
1.09%208.781.0%$258.62m
BAXBaxter International Inc.
0.79%74.321.7%$239.57m
EWEdwards Lifesciences Corporation
0.41%152.801.2%$200.43m
COOCooper Companies, Inc.
1.39%237.242.2%$134.05m
XRAYDENTSPLY International Inc.
0.85%44.953.0%$132.85m
WATWaters Corporation
0.37%193.713.4%$132.79m
ZBHZimmer Biomet Holdings, Inc.
0.20%111.731.7%$105.21m

Company Profile

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease, and other cardiovascular disorders including structural heart conditions. The Rhythm Management segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal, and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.